$SPCX

SpaceX Stock Price Recovers As Eric Trump Rallies Behind Elon Musk, Will It Hold?

Eric Trump defended Elon Musk against a Bloomberg column criticizing SpaceX’s delivery record. The article says 911 million restricted SpaceX shares became free to trade, and SPCX shares rose about 4.15% to around $112.76 after a prior 13.61% drop. It cites SpaceX Q earnings: $7.8B revenue (+92%) and $18.4B capex.

Original reporting
Published Aug 7, 2026, 11:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 11:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SpaceX Stock Price Recovers As Eric Trump Rallies Behind Elon Musk, Will It Hold? — source image
Decision brief

The 30-second read

$SPCXNeutralMed
01

Why it matters

A major lock-up expiration increases tradable float from about 5% to about 12%, while the article also cites substantial short interest, setting up conditions for volatility and potential short-cover flows.

02

Market read

Traders get a concrete, time-specific catalyst: 911 million restricted shares become free to trade, alongside heavy short interest and a recent earnings/capex-driven selloff.

03

What to watch

The article flags capex as the prior selloff driver but does not quantify guidance changes; traders may be underweighting whether spending is expected to translate into near-term cash flow.

Relevance 7/10Novelty 6/10Timing: same day lock-up unlock and premarket/late-morning bounce

Background

The piece discusses Eric Trump defending Elon Musk against a Bloomberg overpromising critique and links the stock move to a large restricted-share unlock.

Company-level read

Ticker impact

$SPCXNeutralMedium confidence
Context

SpaceX shares rose about 4% after 911 million restricted shares became free to trade, expanding float and affecting short-cover dynamics.

Expected impact

Near-term volatility likely elevated; upside follow-through depends on whether shorts continue covering into the larger float.

Evidence & confidence

The article ties the same-day price bounce to a large lock-up expiration and notes heavy short interest, both of which can drive fast, flow-driven moves.

Market effects

Highlights how capital spending intensity and equity float mechanics can dominate sentiment for space/launch-adjacent names.

Primarily US-listed trading dynamics given the New York share price and float/unlock mechanics.

Starlink and Falcon 9 reliability references may influence broader investor perception of space infrastructure, though the immediate catalyst is equity-market structure.

Counterpoint

The bounce may be short-covering rather than a fundamental re-rating, so gains could fade if the unlock increases supply faster than demand.

Key entities

  • SpaceX

    Subject of the article, with shares moving on a restricted-share unlock and prior selloff tied to high capital spending.

  • Eric Trump

    Quoted defending Elon Musk and rebutting a Bloomberg column’s overpromising framing.

  • Bloomberg

    Referenced for claims about launch reliability, Starlink profits, and overpromising/underdelivering critique.

Related articles

$SPCXMed

SpaceX Stock Drops 10% as Revenue Beats Expectations

SpaceX shares fell about 10% after its first earnings report as a public company, despite a revenue and adjusted-loss beat, according to Reuters and CNBC. SpaceX reported Q2 revenue of $7.81B (vs est. ~$6.93B) and a net loss of $541M. Investors focused on $18.4B quarterly capex, including $15.83B for AI infrastructure, plus potential post-IPO lock-up selling.

$SPCXMed

SPCX Surges 16%: Lockup Expiration Passes Cleanly

SpaceX (NASDAQ: SPCX) rose 15.8% on Aug. 7, closing at $133.11 after its first post-IPO lockup expiration on Aug. 6 passed without a broad insider selloff. The move followed Q2 results on Aug. 4, when revenue rose 92% to $7.81B. Next unlocks are Aug. 20 and late September.

$SPCXMed

Top Analyst Drops Sharp Take on SpaceX Stock

Argus Research upgraded newly public SpaceX (NASDAQ:SPCX) to Buy from Hold and set a $160 price target. The firm cited Q2 results with revenue up 92% to $7.8B versus $6.93B consensus and a $541M loss, better than expected. Argus expects revenue near $110B in 2027, supporting a ~20x projected-sales valuation amid concerns over rising AI infrastructure spending and share unlocks.

$SPCXMed

SpaceX Stock Surges 10.5% as Argus Sees Rapid AI Payback

Space Exploration Technologies (NASDAQ:SPCX) rose over 12% in Friday trading after Argus upgraded the stock to Buy from Hold and set a $160 price target. Argus cited faster-than-expected AI spending payback. The company reported Q revenue up 92% to $7.81B, adjusted EBITDA up to $3.54B, and AI revenue up 247% to $2.56B, with AI segment profit. Net loss was $541M and AI capex was $15.83B.